Ultra Low Dose LNG IUS

Product Overview

Alternative Name: LNG Contraceptive IUS 12 (LCS12)

Development Status: Active Development

Target: Female

Mode: Hormonal

Delivery Type: Intrauterine

Duration Type: Long-acting

Description: A low-dose levonorgestrel contraceptive intrauterine system (LCS), LCS12 delivers 12 µg/24h and is effective for 3 years. It is under development by Bayer Healthcare.

Updated date: May 30, 2018

Vertical Tabs

Status

Project Phase: Post-development

Project Stage: Regulatory

Status Details:
  • In Nov. 2015, Bayer preregistered the product for contraception in the European Union.

Download Product Report